SICHUAN CHUANDA HUAXI PHARMACEUTICAL Co.,Ltd is a modern joint-stock hi-tech enterprise restructured in December 2003 based on the pharmaceutical factory of the former West China University of Medical Sciences established in 1958. With a registered capital of RMB80 million Yuan, the company is invested by five shareholders, namely, Sichuan University Hi-tech Group Co., Ltd., Sichuan Hanlinyuan Sci-tech Co., Ltd., Chengdu Venture Capital Co., Ltd., MOH International Exchange & Cooperation Center, and Sichuan Roads & Bridges Construction Group Co., Ltd.. After development for more than 50 years and with the support of the state-of-the-art technologies from Sichuan University, the company has achieved positive social and economic benefits, and has become a modern TCM pharmaceutical enterprise characterized by the R&D, manufacture and international trade of products including cardiovascular medicines and birth control products.
Located in Chengdu Hi-tech Development Zone, the company occupies a land area of 78 mu, has GMP-certified modern workshops designed for various dosage forms and product varieties, and manufactures more than 50 products including Lemai Granules, Shengmai Injection, Shenmai Injection, Xindakang Tablets, Levonorgestrel and Ethinylestradiol Tablets (Triphasic) and Tongqiaobiyan Capsules. The company sells its products to 31 provinces, municipalities and autonomous regions of China and also maintains a stable overseas market. Its products have been sold to the Japanese market for years and have received favorable comments from users there. At present, the company is expanding its international markets to Vietnam and Canada. The birth control products manufactured by the company are designated as products for government procurement. The company was successively awarded titles such as the “Top 30 Pharmaceutical Manufacturing Enterprise of Sichuan Province with Best Performance”, the “Key and Preponderant Enterprise”, the “Little Giant Enterprise of Sichuan Province”, the “Credible Enterprise”, and the “Class-A Credit Rating Taxpayer”, and its West China brand Shenmai Injection and Lemai Granules have received the honorary title of “Famous Brand Product of Sichuan”.
Looking into the future, Chuanda West China Pharmaceutical will carry on the profound cultural connotations of Sichuan University and rely on its sci-tech strength to advance and implement the TCM industrial modernization program, keep improving the enterprise’s core competitiveness through its demand-oriented R&D, quality-centered manufacture, enduser-based marketing, and its preciseness-and-pragmatism-focused corporate culture, strengthen its foreign exchange and cooperation, and make unremitting endeavor to positively lead the modern TCM industry and continuously push forward the cause of human health.